M

Mega Genomics Ltd
HKEX:6667

Watchlist Manager
Mega Genomics Ltd
HKEX:6667
Watchlist
Price: 7.095 HKD Market Closed
Market Cap: HK$1.6B

Intrinsic Value

The intrinsic value for Mega Genomics Ltd (6667) under the Base Case is 4.703 HKD. Compared with the current market price of 7.095 HKD, the stock appears Overvalued by 34% .

Intrinsic value calculated using DCF
HK$4.703
Other reference points

Do our valuations actually work? See backtest results .

Intrinsic Value
HK$4.703
Overvaluation 34%
Intrinsic Value
Price HK$7.095
M
Monitor Mega Genomics Ltd
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value HK$3.76
Get notified when the price drops into your buy zone
Current Price HK$7.1
Intrinsic Value HK$4.7
Margin of Safety 20% HK$3.76
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Ask AI Assistant
What other research platforms think about Mega Genomics Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Mega Genomics Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Mega Genomics Ltd.

Explain Valuation
Alternatives to Mega Genomics Ltd

Fundamental Analysis

Financials

Revenue & Expenses Breakdown
Mega Genomics Ltd

Efficiency

Earnings Waterfall
Mega Genomics Ltd

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one Mega Genomics Ltd stock?

The intrinsic value for Mega Genomics Ltd (6667) under the Base Case is 4.703 HKD.

Is Mega Genomics Ltd stock undervalued or overvalued?

Compared with the current market price of 7.095 HKD, the stock appears Overvalued by 34% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett